BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30600480)

  • 1. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and therapeutic vaccines for chronic HBV infection.
    Lang-Meli J; Neumann-Haefelin C; Thimme R
    Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus: from immunobiology to immunotherapy.
    Grimm D; Heeg M; Thimme R
    Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of HBV-Specific CD8
    Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
    Front Immunol; 2019; 10():2240. PubMed ID: 31620140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen
    Hoogeveen RC; Dijkstra S; Bartsch LM; Drescher HK; Aneja J; Robidoux MP; Cheney JA; Timm J; Gehring A; de Sousa PSF; Ximenez L; Peliganga LB; Pitts A; Evans FB; Boonstra A; Kim AY; Lewis-Ximenez LL; Lauer GM
    J Hepatol; 2022 Nov; 77(5):1276-1286. PubMed ID: 35716846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.
    Hoogeveen RC; Boonstra A
    Front Immunol; 2020; 11():401. PubMed ID: 32194573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?
    Yang HC; Kao JH
    Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):129-31. PubMed ID: 25623202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepant Clinical Significance of CD28
    Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
    Lau GK; Suri D; Liang R; Rigopoulou EI; Thomas MG; Mullerova I; Nanji A; Yuen ST; Williams R; Naoumov NV
    Gastroenterology; 2002 Mar; 122(3):614-24. PubMed ID: 11874993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive response in hepatitis B virus infection.
    Loggi E; Gamal N; Bihl F; Bernardi M; Andreone P
    J Viral Hepat; 2014 May; 21(5):305-13. PubMed ID: 24674098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
    J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.